StockNews.com Downgrades Phibro Animal Health (NASDAQ:PAHC) to Buy

Phibro Animal Health (NASDAQ:PAHC) was downgraded by investment analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued on Thursday.

Several other analysts have also recently weighed in on PAHC. Barclays lifted their price target on shares of Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a report on Tuesday, November 12th. Morgan Stanley lifted their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Tuesday, December 17th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $20.50.

Phibro Animal Health Price Performance

Shares of Phibro Animal Health stock opened at $23.69 on Thursday. The company’s fifty day simple moving average is $21.89 and its two-hundred day simple moving average is $21.63. Phibro Animal Health has a 12-month low of $10.03 and a 12-month high of $25.98. The firm has a market cap of $959.45 million, a PE ratio of 55.09, a price-to-earnings-growth ratio of 0.56 and a beta of 0.52. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81.

Phibro Animal Health (NASDAQ:PAHC) last posted its earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 21.59% and a net margin of 1.67%. As a group, equities analysts expect that Phibro Animal Health will post 1.62 EPS for the current year.

Institutional Investors Weigh In On Phibro Animal Health

Several hedge funds have recently bought and sold shares of PAHC. nVerses Capital LLC purchased a new position in shares of Phibro Animal Health during the third quarter valued at approximately $70,000. Quantbot Technologies LP bought a new position in Phibro Animal Health during the 3rd quarter valued at approximately $70,000. China Universal Asset Management Co. Ltd. raised its stake in Phibro Animal Health by 63.7% during the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock valued at $88,000 after buying an additional 1,522 shares during the last quarter. New York State Teachers Retirement System boosted its holdings in Phibro Animal Health by 16.7% in the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock worth $114,000 after acquiring an additional 775 shares in the last quarter. Finally, CWM LLC grew its stake in shares of Phibro Animal Health by 190.8% in the third quarter. CWM LLC now owns 6,363 shares of the company’s stock worth $143,000 after acquiring an additional 4,175 shares during the last quarter. Institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.